Search bioRxiv⌕ Search

Biology subjects

Lamers, C.

Publications and source records attributed to Lamers, C..

2 recordsLinked to original sources

A Quantum Lens on Molecular Design: A Machine-Learned Energy Function from Interacting Quantum Atoms.

Accurate predictions of the interactions (covalent bonds and non-covalent contacts between atoms) in a molecular system require scalable, accurate, and interpretable energy functions. While classical force fields and knowledge-based energy functions struggle to capture key electronic effects, quantum chemistry approaches such as density functional theory (DFT) provide the necessary accuracy but remain computationally demanding. Furthermore, gaining insight into interactions requires energy decomposition schemes. The Interacting Quantum Atoms (IQA) scheme is exceptionally attractive, offering a chemically intuitive, electron density (ED) topologically based separation into intra- and interatomic contributions, however its high computational cost remains a significant barrier for application to larger systems or tasks like ligand screening in drug discovery. We address these limitations by introducing a novel machine learning (ML) framework to predict accurate energies derived from the IQA scheme together with a comprehensive dataset of molecular systems and their calculated IQA decomposed energies. It enables the rapid and accurate prediction of DFT single point energies and dissects these energies in a physically meaningful and chemically intuitive manner. Our method predicts all intra-atomic energies and inter-atomic interaction energies (covalent and non-covalent) within a defined distance cutoff, providing an energy function that decomposes the total energy into specific atomic contributions. This advance makes the IQA method viable for analyzing interaction energies in applications previously inaccessible due to computational expense, such as elucidating ligand-binding mechanisms and informing rational drug design.

bioinformatics↗

Computer-guided design of Z domain peptides with improved inhibition of VEGF

Computational protein design is becoming increasingly helpful in the development of new protein therapeutics with enhanced efficacy, specificity, and minimal side effects, for precise modulation of biological pathways. In vascular biology, the interaction between vascular endothelial growth factor A (VEGFA) and its receptors (VEGFR1-R3) is a pivotal process underlying blood vessel growth. Dysregulation of this pathway contributes to diseases such as cancer and diabetic retinopathy. Existing VEGFA inhibitors are effective but have limitations, driving interest in peptide-based therapeutics. Peptide inhibitors offer advantages, including reduced toxicity, improved formulation flexibility, and enhanced stability. This study leverages computational tools, particularly ProteinMPNN and Rosetta, to design optimized peptide-based VEGFA inhibitors. Building on the existing peptide templates mini-Z-1 and Z-1-2, new sequences were computationally predicted and experimentally validated. A novel peptide with improved affinity (KD = 6.2 {micro}M) compared to mini-Z-1 (KD = 9.3 {micro}M) was found, requiring only one round of design and testing. The integration of ProteinMPNN and Rosetta enabled a rapid and cost-effective pipeline for designing potent VEGFA inhibitors, underscoring the potential of computational peptide design in developing next-generation therapeutics targeting angiogenesis-dependent diseases.

biochemistry↗